20 June 2013
23 March 1992
Laboratorios Saval of Santiago in Chile, which is the third largest drugmaker in the ranking compiled by the national and...
23 March 1992
Laboratorios Profarma is one of Chile's smaller national pharmaceutical companies, but its size is not indicative of its importance in...
23 March 1992
Glaxo's 5-HT3 receptor antagonist anti-emetic Zofran (ondansetron) represents a great improvement on earlier anti-emetics for chemotherapy regimens that include cisplatin,...
23 March 1992
UK pharmaceuticals group Medeva is continuing its program of buying and developing pharmaceutical products with short development times with the...
23 March 1992
Genentech's recombinant human deoxyribonuclease I (DNase) has been found to be safe in the treatment of cystic fibrosis patients. And...
23 March 1992
Pierre Fabre of France and US-based R P Scherer have entered into a collaborative agreement targeted at the development and...
23 March 1992
Oral use of Pfizer's triazole antifungal Diflucan (fluconazole) has been deemed superior to weekly intravenous injections of amphotericin B to...
16 March 1992
Swedish company Gambro reported sales up 12.9% to 5.62 billion Swe-dish kroner ($943.8 million) for 1991, and pretax earnings of...
16 March 1992
Familial defective apolipoprotein B-100 (FDB), an autosomal dominant disorder characterized by hyper-cholesterolemia, has been shown to be responsive to treatment...
16 March 1992
A new alliance with possible developments in the biomedical sector has been set up recently in Italy. Under a preliminary...